Role of contrast enhanced ultrasonography in the assessment of hepatic metastases: A review

World Journal of Hepatology

Volumn 2, Issue 1, 2010, Pages 8-15

  Larsen, Lars Peter Skovgaard ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Contrast enhanced ultrasound; Liver neoplasms; Metastasis; Ultrasound; Ultrasound contrast agent

Indexed keywords

EID: 79958141118     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v2.i1.8     Document Type: Article

References (53)

1. Tong D, Russell AH, Dawson LE, Wisbeck W. Second laparotomy for proximal colon cancer. Sites of recurrence and implications for adjuvant therapy. Am J Surg 1983; 145: 382-386
2. Gilbert JM, Jeffrey I, Evans M, Kark AE. Sites of recurrent tumour after 'curative' colorectal surgery: implications for adjuvant therapy. Br J Surg 1984; 71: 203-205
3. Russell AH, Tong D, Dawson LE, Wisbeck W. Adenocarcinoma of the proximal colon. Sites of initial dissemination and patterns of recurrence following surgery alone. Cancer 1984; 53: 360-367
4. Pickren JW, Tsuka Y, Lane WW. Liver metastases. In: Weiss L, Gilbert HA, editors. Liver metastasis. Boston: GK Hall Medical Publischers, 1982: 2-18
5. Cosgrove DO. Malignant liver disease. In: Meire HB, Cosgrove DO, Dewbury KC, Farrant P, editors. Clinical ultrasound: a comprehensive text, 2nd ed. London: Churchill Livingstone, 2001: 211-231.
6. Robinson PJ. Imaging liver metastases: current limitations and future prospects. Br J Radiol 2000; 73: 234-241
7. Karhunen PJ. Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 1986; 39: 183-188
8. Edmondson HA, Craig JR. Neoplasms of the liver. In: Schiff L, editor. Diseases of the liver, 8th ed. Philadelphia: Lippincott, 1987
9. Kreft B, Pauleit D, Bachmann R, Conrad R, Krämer A, Schild HH. [Incidence and significance of small focal liver lesions in MRI] Rofo 2001; 173: 424-429
10. Jones EC, Chezmar JL, Nelson RC, Bernardino ME. The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT. AJR Am J Roentgenol 1992; 158: 535-539
11. Schwartz LH, Gandras EJ, Colangelo SM, Ercolani MC, Panicek DM. Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 1999; 210: 71-74
12. Ohlsson B, Nilsson J, Stenram U, Akerman M, Tranberg KG. Percutaneous fine-needle aspiration cytology in the diagnosis and management of liver tumours. Br J Surg 2002; 89: 757-762
13. Wernecke K, Rummeny E, Bongartz G, Vassallo P, Kivelitz D, Wiesmann W, Peters PE, Reers B, Reiser M, Pircher W. Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging. AJR Am J Roentgenol 1991; 157: 731-739
14. Glover C, Douse P, Kane P, Karani J, Meire H, Mohammadtaghi S, Allen-Mersh TG. Accuracy of investigations for asymptomatic colorectal liver metastases. Dis Colon Rectum 2002; 45: 476-484
15. Oldenburg A, Hohmann J, Foert E, Skrok J, Hoffmann CW, Frericks B, Wolf KJ, Albrecht T. Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue. Ultraschall Med 2005; 26: 277-284
16. Bruneton JN, Raffaelli C, Balu-Maestro C, Padovani B, Chevallier P, Mourou MY. Sonographic diagnosis of solitary solid liver nodules in cancer patients. Eur Radiol 1996; 6: 439-442
17. Valls C, Andia E, Sanchez A, Guma A, Figueras J, Torras J, Serrano T. Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT. Radiology 2001; 218: 55-60
18. Portugaller HR, Stacher R, Komaz G, Aschauer M, Hausegger KA, Szolar DH. [The value of different spiral CT phases in the detection of liver metastases] Rofo 2002; 174: 452-458
19. Rappeport ED, Loft A. Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)- enhanced MR imaging, computed tomography and positron emission tomography. Abdom Imaging 2007; 32: 624-634
20. Kim YK, Ko SW, Hwang SB, Kim CS, Yu HC. Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur Radiol 2006; 16: 1337-1345
21. van Erkel AR, Pijl ME, van den Berg-Huysmans AA, Wasser MN, van de Velde CJ, Bloem JL. Hepatic metastases in patients with colorectal cancer: relationship between size of metastases, standard of reference, and detection rates. Radiology 2002; 224: 404-409
22. Albrecht T, Hoffmann CW, Schmitz SA, Schettler S, Overberg A, Germer CT, Wolf KJ. Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases. AJR Am J Roentgenol 2001; 176: 1191-1198
23. Konopke R, Kersting S, Bergert H, Bloomenthal A, Gastmeier J, Saeger HD, Bunk A. Contrast-enhanced ultrasonography to detect liver metastases : a prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy. Int J Colorectal Dis 2007; 22: 201-207
24. Hohmann J, Skrok J, Puls R, Albrecht T. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue] Rofo 2003; 175: 835-843
25. Cosgrove D. Ultrasound contrast agents: an overview. Eur J Radiol 2006; 60: 324-330
26. Albrecht T. Detection and characterisation of liver metastases. In: Lencioni R, editor. Enhancing the role of ultrasound with contrast agents. Pisa: Springer-Verlag Italia, 2006: 53-67
27. Albrecht T, Blomley M, Bolondi L, Claudon M, Correas JM, Cosgrove D, Greiner L, Jäger K, Jong ND, Leen E, Lencioni R, Lindsell D, Martegani A, Solbiati L, Thorelius L, Tranquart F, Weskott HP, Whittingham T. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med 2004; 25: 249-256
28. Jang HJ, Kim TK, Wilson SR. Imaging of malignant liver masses: characterization and detection. Ultrasound Q 2006; 22: 19-29
29. Cosgrove D, Blomley M. Liver tumors: evaluation with con-trast-enhanced ultrasound. Abdom Imaging 2004; 29: 446-454
30. Konopke R, Bunk A, Kersting S. Contrast-enhanced ultrasonography in patients with colorectal liver metastases after chemotherapy. Ultraschall Med 2008; 29 Suppl 4:S203-S209
31. Quaia E, D'Onofrio M, Palumbo A, Rossi S, Bruni S, Cova M. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol 2006; 16: 1599-1609
32. Dietrich CF, Kratzer W, Strobe D, Danse E, Fessl R, Bunk A, Vossas U, Hauenstein K, Koch W, Blank W, Oudkerk M, Hahn D, Greis C. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 2006; 12: 1699-1705
33. Piscaglia F, Corradi F, Mancini M, Giangregorio F, Tamberi S, Ugolini G, Cola B, Bazzocchi A, Righini R, Pini P, Fornari F, Bolondi L. Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer. BMC Cancer 2007; 7: 171
34. Larsen LP, Rosenkilde M, Christensen H, Bang N, Bolvig L, Christiansen T, Laurberg S. Can contrast-enhanced ultrasonography replace multidetector-computed tomography in the detection of liver metastases from colorectal cancer? Eur J Radiol 2009; 69: 308-313
35. Dalla Palma L, Bertolotto M, Quaia E, Locatelli M. Detection of liver metastases with pulse inversion harmonic imaging: preliminary results. Eur Radiol 1999; 9 Suppl 3: S382- S387
36. Esteban JM, Molla MA, Tomas C, Maldonado L. Improved detection of liver metastases with contrast-enhanced wideband harmonic imaging: comparison with CT findings. Eur J Ultrasound 2002; 15: 119-126
37. Harvey CJ, Blomley MJ, Eckersley RJ, Cosgrove DO, Patel N, Heckemann RA, Butler-Barnes J. Hepatic malignancies: improved detection with pulse-inversion US in late phase of enhancement with SH U 508A-early experience. Radiology 2000; 216: 903-908
38. Larsen LP, Rosenkilde M, Christensen H, Bang N, Bolvig L, Christiansen T, Laurberg S. The value of contrast enhanced ultrasonography in detection of liver metastases from colorectal cancer: a prospective double-blinded study. Eur J Radiol 2007; 62: 302-307
39. Konopke R, Kersting S, Saeger HD, Bunk A. [Detection of liver lesions by contrast-enhanced ultrasound -- comparison to intraoperative findings] Ultraschall Med 2005; 26: 107-113
40. Janica JR, Lebkowska U, Ustymowicz A, Augustynowicz A, Kamocki Z, Werel D, Polaków J, Kedra B, Pepinski W. Contrast-enhanced ultrasonography in diagnosing liver metastases. Med Sci Monit 2007; 13 Suppl 1: 111-115
41. Leen E, Ceccotti P, Moug SJ, Glen P, MacQuarrie J, Angerson WJ, Albrecht T, Hohmann J, Oldenburg A, Ritz JP, Horgan PG. Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection? Ann Surg 2006; 243: 236-240
42. Torzilli G, Palmisano A, Del Fabbro D, Marconi M, Donadon M, Spinelli A, Bianchi PP, Montorsi M. Contrastenhanced intraoperative ultrasonography during surgery for hepatocellular carcinoma in liver cirrhosis: is it useful or useless? A prospective cohort study of our experience. Ann Surg Oncol 2007; 14: 1347-1355
43. Fioole B, de Haas RJ, Wicherts DA, Elias SG, Scheffers JM, van Hillegersberg R, van Leeuwen MS, Borel Rinkes IH. Additional value of contrast enhanced intraoperative ultrasound for colorectal liver metastases. Eur J Radiol 2008; 67: 169-176
44. Bipat S, van Leeuwen MS, Comans EF, Pijl ME, Bossuyt PM, Zwinderman AH, Stoker J. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis. Radiology 2005; 237: 123-131
45. Seitz K. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma and liver metastases. Ultraschall Med 2005; 26: 267-269
46. Claudon M, Cosgrove D, Albrecht T, Bolondi L, Bosio M, Calliada F, Correas JM, Darge K, Dietrich C, D'Onofrio M, Evans DH, Filice C, Greiner L, Jäger K, Jong N, Leen E, Lencioni R, Lindsell D, Martegani A, Meairs S, Nolsøe C, Piscaglia F, Ricci P, Seidel G, Skjoldbye B, Solbiati L, Thorelius L, Tranquart F, Weskott HP, Whittingham T. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)-update 2008. Ultraschall Med 2008; 29: 28-44
47. Dietrich CF. Characterisation of focal liver lesions with contrast enhanced ultrasonography. Eur J Radiol 2004; 51 Suppl: S9-S17
48. Romanini L, Passamonti M, Aiani L, Cabassa P, Raieli G, Montermini I, Martegani A, Grazioli L, Calliada F. Economic assessment of contrast-enhanced ultrasonography for evaluation of focal liver lesions: a multicentre Italian experience. Eur Radiol 2007; 17 Suppl 6: F99-F106
49. Faccioli N, D'Onofrio M, Comai A, Cugini C. Contrastenhanced ultrasonography in the characterization of benign focal liver lesions: activity-based cost analysis. Radiol Med 2007; 112: 810-820
50. Mostbeck G. [CEUS from a radiological standpoint: dream and reality] Ultraschall Med 2009; 30: 125-127
51. Albrecht T, Blomley MJ, Burns PN, Wilson S, Harvey CJ, Leen E, Claudon M, Calliada F, Correas JM, LaFortune M, Campani R, Hoffmann CW, Cosgrove DO, LeFevre F. Improved detection of hepatic metastases with pulseinversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 2003; 227: 361-370
52. Solbiati L, Tonolini M, Cova L, Goldberg SN. The role of contrast-enhanced ultrasound in the detection of focal liver leasions. Eur Radiol 2001; 11 Suppl 3: E15-E26
53. Bernatik T, Strobel D, Hahn EG, Becker D. Detection of liver metastases: comparison of contrast-enhanced wide-band harmonic imaging with conventional ultrasonography. J Ultrasound Med 2001; 20: 509-515